EPISODE · Aug 29, 2008 · 11 MIN
Desvenlafaxine: The Newest Antidepressant
Host: Leslie P. Lundt, MD Guest: Philip Ninan, MD After many years of trying, Wyeth has received approval and is currently marketing the newest antidepressant in the US -- desvenlafaxine. What do you need to know about this medicine? Host Dr. Leslie Lundt welcomes Dr. Philip Ninan, vice president for Neuroscience Global Medical Affairs at Wyeth Pharmaceuticals to discuss the ins and outs of desvenlafaxine.
Embed this episode
NOW PLAYING
Desvenlafaxine: The Newest Antidepressant
0:00
11:59
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Clinician's Roundtable?
This episode is 11 minutes long.
When was this Clinician's Roundtable episode published?
This episode was published on August 29, 2008.
Can I download this Clinician's Roundtable episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!